Alembic Pharma raises Rs 150 crore via NCDs
The NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
C2 Pharma acquires Digoxin API Portfolio from Nobilus Ent to guarantee long-term quality and supply…
A fully redundant supply of Digoxin API from C2 PHARMA will be available via two CMO manufacturing sources at Nobilus in Poland…
Indian Pharma Industry witnesses new trends introduced by Schott Kaisha
One-of-its kind roadshow hosted more than 500 customers, partners and prospects under one roof in Ahmedabad, Bengaluru,…
Commonly used heart drug may up cardiac arrest risk
Sudden cardiac arrest is lethal in minutes if untreated
Lilly’s combo therapy succeeds in late-stage lung cancer study
Previously untreated patients with metastatic non-small cell lung cancer taking a combination of Lilly’s Cyramza and Roche’s…
FDA approves generic valsartan amid drug shortage
The FDA said it had sped up the review of the generic from India’s Alkem Laboratories before its approval
Sun Pharma raises stake in Russia’s PJSC Biosintez to 96.96 pc
The company's wholly-owned subsidiary, Sun Pharma (Netherlands) BV, has increased its shareholding in PJSC Biosintez by way of…
Glenmark gets USFDA nod for generic version of acne treatment gel
The approval is for Clindamycin and Benzoyl Peroxide Gel, one per cent/five per cent, a generic version of BenzaClin1 Gel, one per…
LTE appoints India and South-East Asia exports manager
Kolkata-based Ashim Chakravarty, who has 20 years of professional experience in the life sciences industry, has been given the…
USFDA issues import alert on Hospira’s Chennai plant
The alert was imposed after the regulator found lapses with regard to good manufacturing practice (CGMP) regulations
Zydus Cadila gets USFDA nod to market generic anti-diabetic drug
The company has received tentative approval from USFDA to market Sitagliptin and Metformin Hydrochloride extended-release tablets…
SC asks ex-Ranbaxy promoters to apprise how they’ll comply with Rs 3500 cr arbitral award
The bench headed by Chief Justice Ranjan Gogoi has asked the Singh brothers who promoted the pharmaceutical company, to appear…
Lupin responds to US FDA’s OAI letter
Lupin is in the process of sending further updates of its corrective actions to the US FDA and remains hopeful of a positive…
Pall Corporation in agreement with ARTeSYN Biosolutions
Under the agreement, Pall Biotech will distribute ARTeSYN’s standard hardware and liner components off the shelf
Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia
She was recognised for her pioneering entrepreneurial role in the field of biotechnology and for her sustained significant…
Roche’s Tecentriq notches win in breast cancer with US approval
The FDA’s OK was based on a trial that showed the drug cocktail helped stave off the disease’s advance by a median 7.4 months,…
Bayer Roundup cancer trial goes to jury after closing arguments
Hardeman’s lawyer, during her closing arguments had said Hardeman had “extreme” exposure to Roundup, spraying the chemical more…
National Cancer Institute chief Norman Sharpless to serve as acting FDA head
Cancer experts and advocates praised the appointment of Sharpless as acting FDA chief after Scott Gottlieb’s abrupt resignation…
Regeneron/Sanofi wins US approval for expanded use of skin drug
The US Food and Drug Administration said it approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA’s eczema drug…
SPARC inks research collaboration pact with China’s HitGen
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments